Clinical Trials Directory

Trials / Unknown

UnknownNCT05082168

Capnodynamic Monitoring of Cardiorespiratory Function in Critically Ill Patients

Capnodynamic Monitoring of Cardiorespiratory Function in Patients Admitted to the Intensive Care Unit With COVID-19 Infection, Sepsis and Following Cardiac Surgery

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
South West Sydney Local Health District · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Capnodynamic monitoring has the potential to offer continuous and non-invasive measurements of heart and lung function in patients requiring ventilation in an intensive care setting. Since mechanical ventilation with full patient synchronization is commonly used in ICU, capnodynamic monitoring can be immediately embedded in clinical care and compared to current methods of monitoring cardiac output, lung volumes and oxygen delivery. This observational study will explore capnodynamic monitoring in mechanically ventilated patients with a range of cardiorespiratory compromise.

Detailed description

This study aims to: 1. compare the estimation of cardiac output (CO) using the capnodynamic method (COEPBF) with contemporary reference methods; 2. compare the estimation of mixed venous oxygen saturation (SmvO2) with invasively obtained blood gas analyses; 3. generate observational data on end-expiratory lung volume (EELV) when ventilator settings, and in particular PEEP, are changed; 4. combine 1-3 to provide a physiological construct of cardiorespiratory function

Conditions

Interventions

TypeNameDescription
DEVICECapnodynamic monitoringIn patients fully synchronized with mechanical ventilation, the capnodynamic method calculates the effective pulmonary blood flow, the end-expiratory lung volume and estimates the mixed venous oxygen saturation. The capnodynamic method uses short inspiratory or expiratory pauses to induce small changes in CO2 concentration the enable the mole balance to be resolved for the capnodynamic equation: ELV x \[(FACO2(n)-FACO2(n-1)\] = delta(n) x EPBF \[CvCO2(n)\] - VTCO2.

Timeline

Start date
2021-02-01
Primary completion
2022-12-31
Completion
2023-07-01
First posted
2021-10-18
Last updated
2021-10-18

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT05082168. Inclusion in this directory is not an endorsement.